Keywords: encouraging, data, medarex, cancer, drug, firms, bristol-myers

Encouraging data for Medarex' cancer drug

Article | 25 April 2005

Print This

US firms Medarex and Bristol-Myers Squibb have reported positive results from a Phase II clinical trial of the fully-human anti-CTLA-4 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in